Skip to main content

Papua New Guinea

Tariffs

Download data

3002.12 Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes, antisera and other blood fractions

1 tariff line

3002.12 Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes, antisera and other blood fractions
HS code Product MFN MSG
3002.12.00 Antisera and other blood fractions 0% 0%

Showing 1–1 of 1

HS 3002.12.00

Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes, antisera and other blood fractions

Section VI · Products of the chemical & allied industries › Ch 30 Pharmaceutical products › 30.02 Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures, whether or not modified

Close

Applied duty rates

  • 0% MFN applied rate
  • 0% MSG preferential rate
Exports | US$ thousand
  • To the world
  • Within the Commonwealth
Show data
YearTo the worldWithin the Commonwealth
2020$1–
2021$2–
2022$74–
2023$2–
2024$0–
Imports | US$ thousand
  • From the world
  • Within the Commonwealth
Show data
YearFrom the worldWithin the Commonwealth
2020$621$622
2021$1,182$1,176
2022$656$649
2023$1,300$1,258
2024$505$501

Pilot countries

Each country has its own profile: tariff regime, export requirements, a market snapshot and links to official national portals. 

See all countries

Share this page with